HUP0200148A3 - Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents

Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention

Info

Publication number
HUP0200148A3
HUP0200148A3 HU0200148A HUP0200148A HUP0200148A3 HU P0200148 A3 HUP0200148 A3 HU P0200148A3 HU 0200148 A HU0200148 A HU 0200148A HU P0200148 A HUP0200148 A HU P0200148A HU P0200148 A3 HUP0200148 A3 HU P0200148A3
Authority
HU
Hungary
Prior art keywords
cinnamoyl
dimethoxy
prevention
reduction
events associated
Prior art date
Application number
HU0200148A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0200148A2 publication Critical patent/HUP0200148A2/hu
Publication of HUP0200148A3 publication Critical patent/HUP0200148A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0200148A 1999-02-03 2000-02-02 Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention HUP0200148A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11846399P 1999-02-03 1999-02-03

Publications (2)

Publication Number Publication Date
HUP0200148A2 HUP0200148A2 (hu) 2002-05-29
HUP0200148A3 true HUP0200148A3 (en) 2003-06-30

Family

ID=22378760

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200148A HUP0200148A3 (en) 1999-02-03 2000-02-02 Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention

Country Status (17)

Country Link
EP (1) EP1180027A4 (ko)
JP (1) JP2002536326A (ko)
KR (1) KR20010101933A (ko)
CN (1) CN1338930A (ko)
AR (1) AR022475A1 (ko)
AU (1) AU2978500A (ko)
BR (1) BR0007901A (ko)
CA (1) CA2361578A1 (ko)
CO (1) CO5160246A1 (ko)
HU (1) HUP0200148A3 (ko)
IL (1) IL144719A0 (ko)
MX (1) MXPA01007833A (ko)
NO (1) NO20013789L (ko)
PL (1) PL349926A1 (ko)
TR (1) TR200102262T2 (ko)
WO (1) WO2000045810A1 (ko)
ZA (1) ZA200106297B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097650B2 (en) * 2005-07-27 2012-01-17 The Trustees Of Columbia University In The City Of New York Method of treating a condition associated with phosphorylation of TASK-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
KR19990044478A (ko) * 1995-09-07 1999-06-25 간자와 무츠와 2-아실아미노벤즈아미드 유도체 및 혈관내막세포 과잉증식에 기인하는 질환의 예방 및 치료제
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
EP1180027A4 (en) 2004-11-17
AU2978500A (en) 2000-08-25
HUP0200148A2 (hu) 2002-05-29
NO20013789D0 (no) 2001-08-02
TR200102262T2 (tr) 2002-02-21
AR022475A1 (es) 2002-09-04
NO20013789L (no) 2001-09-28
WO2000045810A1 (en) 2000-08-10
KR20010101933A (ko) 2001-11-15
JP2002536326A (ja) 2002-10-29
EP1180027A1 (en) 2002-02-20
CN1338930A (zh) 2002-03-06
ZA200106297B (en) 2002-07-31
PL349926A1 (en) 2002-10-21
CO5160246A1 (es) 2002-05-30
IL144719A0 (en) 2002-06-30
MXPA01007833A (es) 2002-06-21
BR0007901A (pt) 2001-10-30
CA2361578A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
IL145732A0 (en) α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
PL352100A1 (en) Antagonists of the beta 2 adrenoreceptor
PL348349A1 (en) Antrhranilic acid amides and the use thereof as medicaments
HUP0200638A2 (en) Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0102255A3 (en) Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
IL129270A0 (en) Class "d" amplifier
HU9500063D0 (en) Alfa-pyrimidinyl acrylic acid derivatives, the preparation thereof and their use as fungicide
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
HK1048318B (zh) 取代的3-苯基-5-烷氧基-1,3,4-噁二唑-2-酮及其作為脂酶抑制劑的用途
HUP0200148A3 (en) Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
HUP0201729A2 (en) Inhibitors of the integrin alpha v betha 6
HUP0200129A3 (en) Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention
IL149607A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3 benzazocines and the use thereof as medicaments
IT1320401B1 (it) Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura.
EP1172359A4 (en) N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE, AND ITS USE AS AN INHIBITOR OF TNF PRODUCTION- $ g (a)
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
SI1235809T1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
IL129642A0 (en) Process for the preparation of optically active 1,4-benzodioxane-2- carboxylic acid and derivatives thereof
ZA997090B (en) "A composition for the treatment of wood".
SI1214302T1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
EG23327A (en) Metraplant "iucd".
ZA997168B (en) "Shelving".